Cogo Attention Training Programme is a digital solution provided by Neeuro. Paired with the Neero SenzeBand 2, it encompasses several categories of digital health solutions including Digital Therapeutics (DTx) and DIY Care.

Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics

Digital Therapeutics​ - Cogo Attention Training Programme

Cogo is a patented, scientifically validated digital therapeutic and attention training programme based on Brain-Computer Interface (BCI) technology, suitable for 6 to 12 years old children who exhibit inattentive symptoms. It is jointly developed by A*STAR’s Institute for Infocomm Research (I2R), Institute of Mental Health, and Duke-NUS Medical School in Singapore through a decade of research and clinical trials. 

Paired with Neeuro SenzeBand 2, the Cogo Attention Training Programme is a 24-session programme. Practitioners can supervise the child's progress either at the clinic or through an online dashboard where the session achievements are tracked. Parents can also receive a progress report as the child completes different sessions. The programme can be completed within 2 to 3 months, at 2 or 3 sessions per week, 30 minutes per session. 

Resources that are helpful in understanding about the Cogo Attention Training Programme includes: Exploring the Potential of Digital Therapeutics (WEBINAR) and A Buyer’s Guide to Digital Therapeutics

Neeuro SenzeBand 2​

The Neeuro SenzeBand 2 is a non-invasive device for capturing EEG (brainwaves) signals. It consists of 7 dry electrodes with five located on the prefrontal cortex and two on the sides. Together with Neeuro’s machine learning algorithms, it interprets these EEG signals into various mental states, like attention, relaxation, mental workload, fatigue, stress, and many more. This provides insightful biofeedback for measurements used in real-time to drive interventions for various brain health challenges.

FDA Breakthrough Software as a Medical Device (SaMD) for early detection, remote monitoring of disease progression and measurement of the impact to therapy for at risk neurodegenerative patients. Psychomotor and cognition detection, monitoring, and therapeutic measurement. 

The child or user's privacy is top priority. There is available dashboard for practitioners to access and track the performance of the child but the names of the individuals need not be divulged.

Dashboard is also available to practitioner anytime, anywhere as it is saved in the cloud with top level security.

Cogo is a cutting-edge Attention Training Programme that utilizes advanced Digital Therapeutics to improve children's attention levels. Unlike other attention training programmes, Cogo utilizes a paired EEG device to measure attention levels, ensuring a personalized, structured, and targeted training programme. 

Emotional

• Gamified approach to provide a fun element to training.​
• A reward system during training that provides positive feedback.

Personal

• Training parameters are personalised and dynamically adjusted.​
• Measured outcomes and transfer effects to academic questions.

nQ Medical is the only FDA cleared SaMD that helps

physicians detect and track progression of diseases of cognition and motor.

• No proprietary equipment
• No task-based apps
• Generates data every 90 secs
• Near 100% adherence



Your own device continuously assesses your neurological health… automatically, everyday